Global Neurovascular Devices Market Set to Grow Steadily at a CAGR of ~8% by 2032 | DelveInsight
The growth of the neurovascular devices market is largely fueled by the increasing burden of neurovascular disorders, rapid technological advancements in devices, a growing preference for minimally invasive procedures, expanding stroke awareness and screening initiatives, and heightened product development efforts by key market players.
New York, USA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Global Neurovascular Devices Market Set to Grow Steadily at a CAGR of ~8% by 2032 | DelveInsight
The growth of the neurovascular devices market is largely fueled by the increasing burden of neurovascular disorders, rapid technological advancements in devices, a growing preference for minimally invasive procedures, expanding stroke awareness and screening initiatives, and heightened product development efforts by key market players.
DelveInsight’s Neurovascular Devices Market Insights report provides the current and forecast market analysis, individual leading neurovascular devices companies’ market shares, challenges, neurovascular devices market drivers, barriers, trends, and key neurovascular devices companies in the market.
Neurovascular Devices Market Summary
- 2024 Neurovascular Devices Market Size: USD 3.6 Billion
- 2032 Projected Neurovascular Devices Market Size: USD 6.8 Billion
- Neurovascular Devices Market Growth Rate (2025-2032): ~8%
- Largest Neurovascular Devices Market: North America
- Largest Product Type Segment: Carotid Artery Stents
- Key Companies in the Neurovascular Devices Market: Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others
To read more about the latest highlights related to the global neurovascular devices market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr

Key Factors Contributing to the Rise in Growth of the Neurovascular Devices Market
- Increasing prevalence of neurological disorders: The growing incidence of neurological conditions, including stroke, brain aneurysms, and arteriovenous malformations, is significantly driving demand for neurovascular devices. An aging global population, increasingly sedentary lifestyles, and the rising prevalence of risk factors such as hypertension and diabetes are contributing to higher disease burden. As a result, there is an increased need for advanced diagnostic and minimally invasive treatment options, accelerating the adoption of neurovascular devices and supporting market expansion.
- Increasing technological advancements: Advancements in neurovascular technologies are accelerating market growth. Innovations such as next-generation stent retrievers, flow diverters, embolic coils, and AI-powered imaging systems are improving procedural accuracy, safety, and clinical outcomes. These developments support minimally invasive interventions with shorter recovery times and fewer complications, encouraging wider adoption by hospitals and clinicians and fueling expansion of the neurovascular devices market.
- Rise in demand for minimally invasive neurovascular surgical procedures: Growing demand for minimally invasive neurovascular interventions is driving the expansion of the neurovascular devices market. These procedures offer shorter hospital stays, reduced complication rates, and quicker recovery compared with conventional surgeries. Increasing patient preference and wider physician adoption of advanced techniques are accelerating the use of specialized devices such as stent retrievers, embolic coils, and flow diverters, supporting overall market growth.
Get a sneak peek at the neurovascular devices market dynamics @ Neurovascular Devices Market Trends
Regional Neurovascular Devices Market Insights
North America
- North America held the largest share of the global neurovascular devices market in 2024, accounting for around 30%, driven by advanced healthcare infrastructure, high stroke prevalence, strong adoption of innovative neurointerventional technologies, and supportive reimbursement policies.
- North America continues to strengthen its market leadership, driven by leading medical device companies, sustained R&D investments, and growing awareness programs focused on stroke prevention and treatment.
Europe
- Europe plays a significant role in driving growth in the neurovascular devices market, supported by a high prevalence of neurovascular disorders such as acute ischemic stroke, aneurysms, and arteriovenous malformations, which fuels demand for advanced treatment options.
- Europe is witnessing accelerated adoption of neurovascular devices, including thrombectomy systems, embolic protection devices, stent retrievers, and clot retrieval catheters, due to a growing emphasis on early diagnosis and minimally invasive interventions across healthcare systems.
- Europe further benefits from the presence of key market players and ongoing product innovation, including the development of next-generation thrombectomy and embolic protection devices, thereby supporting sustained market expansion.
Asia-Pacific
- Asia-Pacific is emerging as a major growth driver in the neurovascular devices market due to a rapidly expanding patient pool for neurovascular disorders such as acute ischemic stroke and aneurysms, largely driven by aging populations.
- Asia-Pacific is experiencing rising adoption of advanced neurovascular devices, including thrombectomy systems, stent retrievers, and embolic protection devices, fueled by increasing awareness of early diagnosis and the benefits of minimally invasive procedures.
To know more about why North America is leading the market growth in the neurovascular devices market, get a snapshot of the Neurovascular Devices Market Share
Recent Developmental Activities in the Neurovascular Devices Market
- In June 2025, InspireMD announced that its CGuard® Prime Embolic Prevention System (EPS) received CE Mark approval under the European Medical Device Regulation (MDR) for use in stroke prevention.
- In May 2025, Terumo Interventional Systems announced the commercial launch of its FDA-approved ROADSAVER™ Carotid Stent System. Designed for use with the Nanoparasol® Embolic Protection System, the ROADSAVER Stent System is intended to treat carotid artery stenosis in patients at elevated risk of complications from carotid endarterectomy.
- In March 2025, Boston Scientific launched an updated FilterWire EZ embolic protection system in select European markets. The system features a wire with a 110-micron-pore filter at its tip, designed to capture embolic material while maintaining blood flow and reliably conforming to the artery walls.
What are Neurovascular Devices?
Neurovascular devices are specialized medical tools designed to diagnose, treat, and manage disorders affecting the blood vessels of the brain and spinal cord. These devices are commonly used in minimally invasive endovascular procedures to address conditions such as ischemic and hemorrhagic stroke, cerebral aneurysms, arteriovenous malformations, and intracranial stenosis. They include products like stent retrievers, aspiration catheters, flow diverters, embolization coils, balloons, and intracranial stents, which help restore blood flow, prevent vessel rupture, or block abnormal vessels. By enabling precise intervention within delicate cerebral vasculature, neurovascular devices play a critical role in reducing neurological damage, improving patient outcomes, and lowering the need for open brain surgery.
| Neurovascular Devices Market Report Metrics | Details |
| Coverage | Global |
| Study Period | 2022–2032 |
| Neurovascular Devices Market CAGR | ~8% |
| Neurovascular Devices Market Size by 2032 | USD 6.8 Billion |
| Key Neurovascular Devices Companies | Johnson & Johnson Services Inc., Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corporation, Integer Holdings Corporation, phenox GmbH, Perflow Medical Ltd., Balt, Rapid Medical, ASAHI INTECC CO., LTD., Acandis GmbH, Cerus Endovascular Inc., and others |
Neurovascular Devices Market Assessment
-
Neurovascular Devices Market Segmentation
- Neurovascular Devices Market Segmentation By Product Type: Cerebral Embolization and Aneurysm Coiling Devices [Embolic Coils, Flow Diversion Devices, and Liquid Embolic Agents], Cerebral Balloon Angioplasty and Stenting Systems [Carotid Artery Stents and Embolic Protection Systems], Neurothrombectomy Devices [Clot Retrievers, Suction Devices, and Vascular Snare], and Support Devices [Micro Catheters and Micro Guidewires]
- Neurovascular Devices Market Segmentation By Application: Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others
- Neurovascular Devices Market Segmentation By End User: Stroke, Cerebral Aneurysm, Carotid Artery Stenosis, and Others
- Neurovascular Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the neurovascular devices market are set to emerge as the trendsetter explore @ Neurovascular Devices Market Analysis
Table of Contents
| 1 | Neurovascular Devices Market Report Introduction |
| 2 | Neurovascular Devices Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | Neurovascular Devices Market Key Factors Analysis |
| 6 | Neurovascular Devices Market Porter’s Five Forces Analysis |
| 7 | Neurovascular Devices Market Layout |
| 8 | Neurovascular Devices Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the neurovascular devices market share by 2032? Click to get a snapshot of the Neurovascular Devices Market Size
Related Reports
Neurovascular Catheter Devices Market
Neurovascular Catheter Devices Market Insights, Competitive Landscape and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neurovascular catheter devices companies, including Medtronic, Stryker, Penumbra, Johnson & Johnson (Cerenovus), Terumo Corporation (MicroVention), Integer Holdings, MicroPort, Acandis, Rapid Medical, Asahi Intecc, among others.
Neurovascular Coiling Assist Devices Market
Neurovascular Coiling Assist Devices Market Insights, Competitive Landscape and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neurovascular coiling assist devices companies, including Medtronic, Stryker, Johnson & Johnson (Cerenovus), Penumbra, MicroPort, Terumo (MicroVention), Acandis, Asahi Intecc, Rapid Medical, phenox, Perflow Medical, Balt, Cerus Endovascular, among others.
Neurovascular Embolization Device Market
Neurovascular Embolization Device Market Insights, Competitive Landscape and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neurovascular embolization device companies, including Medtronic PLC, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, among others.
Neurovascular Thrombectomy Devices Market
Neurovascular Thrombectomy Devices Market Insights, Competitive Landscape and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neurovascular thrombectomy devices companies, including Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson Services Inc., Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, Biomedical Solutions Inc., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech, Innova Vascular, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Contact Us Shruti Thakur info@delveinsight.com +14699457679
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.